aXichem AB (publ), that develops and markets natural analogue industrial compounds, has during the beginning of the year seen an increased interest in the company's product for dietary supplements, aXivite. In 2021, as previously communicated, several new dietary supplements with aXivite as active ingredient have been introduced in Europe and the USA. This has resulted in positive attention for the product in the industry and increased activity at aXichem's distributors.

“We are seeing increased interest in both the United States and Europe for aXivite, and also from Asia, where we recently announced a new collaboration. So far this year, we have received two orders for product development from our distributor in Poland, Bart Spólka Sp.k. (BART). Since we signed an agreement with BART in October last year, they have placed three orders, a total of almost one hundred kilos. This feels extra gratifying as it happens during a time when we have been limited by the pandemic. We now look forward to being able to participate in EXPO West in the USA in March, together with our American distributor BERG Nutrition, and continue to build on the exciting commercial relationships we have internationally”, says Torsten Helsing, CEO of aXichem.

This information was published by the contact person below on 10 February 2022, 13:30 CET.